SUNNIFORECAST - A phase II study of Nivolumab in combination with Ipilimumab versus Standard of care in advanced or metastatic non-clear cell renal cell carcinoma - Scheich, S.; Ahrens, M.; Goekbuget, N.; Boleti, E.; Burkholder,; Escudier, B. J.; Goebell, Peter; Gruenwald,; Gschwend, J.; Retz, M.; Hartmann, Arndt; Maroto Rey, J. P.; et al. (2018)
EVALuna2:35894